您当前的位置：
首页 >
文章列表页 >
Clinical Efficacy of Modified Banxia Xiexintang Combined with Vedolizumab in Treatment of Crohn's Disease with Syndrome of Cold and Heat in Complexity
更新时间：2023-12-19

    • Clinical Efficacy of Modified Banxia Xiexintang Combined with Vedolizumab in Treatment of Crohn's Disease with Syndrome of Cold and Heat in Complexity

    • “The latest research has found that the combination of Banxia Xiexin Tang and vedolizumab can improve the efficacy, nutritional status, regulate gut microbiota, reduce inflammatory damage, and is safe for clinical use in the treatment of moderate to severe Crohn's disease.”
    • Chinese Journal of Experimental Traditional Medical Formulae   Vol. 30, Issue 2, Pages: 134-141(2024)

    • DOI：10.13422/j.cnki.syfjx.20240892    

      CLC： R2-0;R22;R242;R2-031;R259;R57;R714.255

    • Received：13 June 2023，

      Published Online：02 November 2023，

      Published：20 January 2024

    移动端阅览

  • JI Zhenliao,WANG Gaoan,FANG Xiangyu,et al.Clinical Efficacy of Modified Banxia Xiexintang Combined with Vedolizumab in Treatment of Crohn's Disease with Syndrome of Cold and Heat in Complexity[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(02):134-141. DOI： 10.13422/j.cnki.syfjx.20240892.

  •  
  •  

0

Views

59

下载量

1

CSCD

Alert me when the article has been cited
提交
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Banxia Xiexintang and Its Disassembled Prescriptions Regulate Colonic Mucosal Immunity in Young Rats with Flora Disorder
Sishenwan Restores Intestinal Barrier in Rat Model of Diarrhea-predominant Irritable Bowel Syndrome Due to Spleen-kidney Yang Deficiency by Regulating Intestinal Flora and Short-chain Fatty Acids
Regulatory Effect of Modified Wumeiwan on Th17/Treg Balance and Intestinal Microbiota in Ulcerative Colitis with Dampness-heat Obstruction Syndrome in Human Flora-associated Model
Effect of Xianlian Jiedu Prescription Regulating Intestinal Flora and CD8+ T Cell Immune Response on Colorectal Cancer

Related Author

Li-rong DAI
Qi-ming CHEN
Xi-ping LIU
Yan-yan LIN
Kan LI
Juan YUE
Yan GE
Pei-qing LI

Related Institution

Gansu Engineering Laboratory for New Products of Traditional Chinese Medicine （TCM）， Gansu Key Laboratory of TCM Excavation and Innovative Transformation，Gansu University of Chinese Medicine
The First Hospital of Lanzhou University
The First Clinical Medical College，Hubei University of Chinese Medicine
Hubei Provincial Hospital of Traditional Chinese Medicine/Affiliated Hospital of Hubei University of Chinese Medicine
Hubei Shizhen Laboratory
0